European Archives - Page 121 of 1109 - European Medical Journal

Improving Vaccine Response in Patients with HIV

This study highlights that both the 2-dose and 3-dose HepB-CpG regimens provide better seroprotection compared to the 3-dose HepB-alum regimen.

How CAD Type Influences Left Ventricular Ejection Fraction Change After PCI

LVEF recovery post-PCI differs by CAD presentation, significantly impacting long-term prognosis, particularly in STEMI patients.

The Role of Circadian Clocks in Inflammasome Activation and Inflammation

These findings provide new insights into how circadian rhythms, through mitochondrial regulation, contribute to inflammatory responses.

Infertility Without Treatment Linked to Autoimmune Disease Risk

Women who experienced infertility without fertility treatment had a higher incidence of systemic autoimmune rheumatic disease…

Metformin Does Not Affect Prostate Cancer Progression Rates

Despite promising preclinical and epidemiological data, metformin does not appear to impact disease progression in men with low-risk prostate cancer.

Mailed Faecal Immunochemical Testing Boosts CRC Screening Rates

A centralised, mailed colorectal cancer screening programme significantly improved screening completion rates in federally qualified health centres.

Whole-Body MRI in Oncology

Whole-body magnetic resonance imaging (WB-MRI) has significantly improved oncological disease management by enabling comprehensive…

Atopic Dermatitis as a Risk Factor for Inflammatory Bowel Disease

Shared genetic, environmental, and microbial factors suggest a potential relationship between these diseases.

Alpha Blockers Linked to Fracture Risk in Female Patients With Chronic Kidney Disease

Alpha blockers increase fracture risk in female CKD patients treated for voiding dysfunction, emphasising the need for cautious prescribing.

Gold crown on blue background

Could Eli Lilly take the crown in the obesity market?

According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.